bluebird bio (BLUE) Insider Trading & Ownership $8.35 +0.09 (+1.09%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends bluebird bio (NASDAQ:BLUE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$5,800.80 Get BLUE Insider Trade Alerts Want to know when executives and insiders are buying or selling bluebird bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BLUE Insider Buying and Selling by Quarter bluebird bio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/6/2025Andrew ObenshainCEOSell140$9.24$1,293.60 12/10/2024Andrew ObenshainCEOSell48$8.40$403.20 2/5/2024Andrew ObenshainCEOSell93$18.00$1,674.00 2/5/2024Thomas J KlimaInsiderSell135$18.00$2,430.00 (Data available from 1/1/2013 forward) BLUE Insider Trading Activity - Frequently Asked Questions Who is on bluebird bio's Insider Roster? The list of insiders at bluebird bio includes Andrew Obenshain, Anne-Virginie Eggimann, Christopher Krawtschuk, Jason Cole, Nick Leschly, Richard A Colvin, and Thomas J Klima. Learn more on insiders at BLUE. What percentage of bluebird bio stock is owned by insiders? 1.40% of bluebird bio stock is owned by insiders. Learn more on BLUE's insider holdings. Which bluebird bio insiders have been selling company stock? The following insiders have sold BLUE shares in the last 24 months: Andrew Obenshain ($67,786.40), Christopher Krawtschuk ($20,430.40), Richard A Colvin ($823.60), and Thomas J Klima ($20,336.80). How much insider selling is happening at bluebird bio? Insiders have sold a total of 1,927 bluebird bio shares in the last 24 months for a total of $109,377.20 sold. bluebird bio Key ExecutivesMr. Andrew Obenshain (Age 50)President, CEO & Director Compensation: $1.04M2 recent tradesMr. Thomas J. Klima (Age 52)Chief Commercial Officer & COO Compensation: $654.97kMr. Richard A. Colvin M.D. (Age 58)Ph.D., Chief Medical Officer Compensation: $696.24kMr. Oliver James Sterling IIICFO & Principal Accounting OfficerMr. Joseph D. Vittiglio Esq. (Age 52)J.D., Chief Legal & Business Officer and Secretary Jess RowlandsHead of Corporate CommunicationsMs. Andrea WaltonChief People OfficerMr. Kasra KasraianSenior Vice President of Technical Development & OperationsMr. Scott ShoemakerSenior Vice President of QualityMs. Sarah AlspachSenior Vice President of External Affairs More Insider Trading Tools from MarketBeat Related Companies Corvus Pharmaceuticals Insider Trading Taysha Gene Therapies Insider Trading Precigen Insider Trading Tango Therapeutics Insider Trading Chimerix Insider Trading biote Insider Trading Trevi Therapeutics Insider Trading Voyager Therapeutics Insider Trading LifeVantage Insider Trading iTeos Therapeutics Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:BLUE) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bluebird bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bluebird bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
